Ferdinando Nicoletti

Pubblicazioni

Titolo Pubblicato in Anno
Expression of the K(+)/Cl(-) cotransporter, KCC2, in cerebellar Purkinje cells is regulated by group-I metabotropic glutamate receptors NEUROPHARMACOLOGY 2016
Metabotropic glutamate 2/3 receptors and epigenetic modifications in psychotic disorders: a review CURRENT NEUROPHARMACOLOGY 2016
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 FRONTIERS IN PHARMACOLOGY 2016
Type-1, but Not Type-5, Metabotropic Glutamate Receptors are Coupled to Polyphosphoinositide Hydrolysis in the Retina NEUROCHEMICAL RESEARCH 2016
Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors NEUROPHARMACOLOGY 2016
Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism. NEUROPHARMACOLOGY 2015
N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans. MOLECULAR PAIN 2015
Antidepressant activity of fingolimod in mice PHARMACOLOGY RESEARCH & PERSPECTIVES 2015
Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels PSYCHIATRY RESEARCH 2015
Differential modulation of AMPK/PPARα/UCP2 axis in relation to hypertension and aging in the brain, kidneys and heart of two closely related spontaneously hypertensive rat strains ONCOTARGET 2015
Depersonalization: an exploratory factor analysis of the Italian version of the Cambridge Depersonalization Scale COMPREHENSIVE PSYCHIATRY 2015
Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons FRONTIERS IN CELLULAR NEUROSCIENCE 2015
O066. Kynurenine pathway metabolites in cluster headache THE JOURNAL OF HEADACHE AND PAIN 2015
The Prevention and Treatment of Delirium in Elderly Patients Following Hip Fracture Surgery. RECENT PATENTS ON CNS DRUG DISCOVERY 2015
Type-1, but Not Type-5, Metabotropic Glutamate Receptors are Coupled to Polyphosphoinositide Hydrolysis in the Retina NEUROCHEMICAL RESEARCH 2015
Xanthurenic Acid Activates mGlu2/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia SCIENTIFIC REPORTS 2015
Targeting type-2 metabotropic glutamate receptors to protect vulnerable hippocampal neurons against ischemic damage MOLECULAR BRAIN 2015
Activation of presynaptic oxytocin receptors enhances glutamate release in the ventral hippocampus of prenatally restraint stressed rats PSYCHONEUROENDOCRINOLOGY 2015
5-HT<inf>2C</inf> serotonin receptor blockade prevents tau protein hyperphosphorylation and corrects the defect in hippocampal synaptic plasticity caused by a combination of environmental stressors in mice PHARMACOLOGICAL RESEARCH 2015
Anti-absence activity of mGlu1 and mGlu5 receptor enhancers and their interaction with a GABA reuptake inhibitor: Effect of local infusions in the somatosensory cortex and thalamus EPILEPSIA 2015

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma